Ann Clin Neurophysiol.
2023;25(1):54-54. 10.14253/acn.2022.24.2.101.e1.
Correction of dosage of the drug: Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
- Affiliations
-
- 1Department of Neurology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- KMID: 2541825
- DOI: http://doi.org/10.14253/acn.2022.24.2.101.e1
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Post-infectious basal ganglia encephalitis and axonal variant of Guillain-Barré syndrome after COVID-19 infection: an atypical case report
- Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report
- Guillain-Barre Syndrome in a Patient with Chemotherapy for HIV Related Burkitt's Lymphoma
- An Unusual Case of Pure Motor Variant of Guillain-Barre Syndrome Initially Presenting with Hemiparesis
- Guillain-Barré Syndrome with Atypical Clinical Course after BNT162b2 COVID-19 Vaccination
